Italy marked a significant milestone at Web Summit Qatar 2026 with its first ever institutional participation, underscoring ...
Alejandro Weinstein, Chairman of Pluri, shares insights on the future of biotechnology and cell-based therapies. Weinstein ...
In a pine forest on Michigan’s Upper Peninsula, the only active nickel mine in the US is nearing the end of its life. At a time when carmakers want the metal for electric-vehicle batteries, nickel ...
Gardiner argues that the pharmaceutical and biotech industries must support early, hands-on exposure to demystify complex ...
Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated immunotherapy for advanced ovarian cancer. Dr. Lindborg has worked in the ...
The science pros at TKOR show the future approach to science and technology.
Kos Biotechnology Partners ("Kos"), a global life sciences investment firm, today announced the closing of a financing round in Epikast, a premier provider of technology-enabled commercial and ...
The business may not be as strong as its performance this year suggests.
BRISTOL, TN / ACCESS Newswire / February 4, 2026 / Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) shareholders approved a transformational merger that converts a clinical-stage biopharmaceutical co ...
Find research and technology infrastructures that provide resources and services to conduct research and foster innovation in ...
National Institutes of Health Director Jayanta Bhattacharya, M.D., Ph.D., spent much of a Senate committee hearing dancing around direct answers—except when it came to vaccines, a topic in which he ...
A local medtech startup behind an AI sepsis diagnostic tool recognized by Time magazine has landed $40 million in funding.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results